Andreas Rohrwasser

age ~56

from Salt Lake City, UT

Also known as:
  • Andy Rohrwasser
  • Andreas R
Phone and address:
2696 Spring Creek Rd, Salt Lake City, UT 84117
8014242868

Andreas Rohrwasser Phones & Addresses

  • 2696 Spring Creek Rd, Salt Lake Cty, UT 84117 • 8014242868
  • Salt Lake City, UT
  • 2696 Spring Creek Rd, Salt Lake Cty, UT 84117 • 8018156310

Work

  • Position:
    Administrative Support Occupations, Including Clerical Occupations

Education

  • Degree:
    Associate degree or higher

Emails

Us Patents

  • Drug Screening And Diagnosis Based On Paracrine Tubular Renin-Angiotensin System

    view source
  • US Patent:
    6495338, Dec 17, 2002
  • Filed:
    Sep 3, 1999
  • Appl. No.:
    09/389242
  • Inventors:
    Andreas Rohrwasser - Salt Lake City UT
    Terry Morgan - Salt Lake City UT
    Jean-Marc Lalouel - Salt Lake City UT
  • Assignee:
    University of Utah Research Foundation - Salt Lake City UT
  • International Classification:
    C12Q 137
  • US Classification:
    435 23, 436 86, 514 2, 530316, 424 9466
  • Abstract:
    The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in an individual by measuring urinary angiotensinogen or angiotensin-I.
  • Drug Screening And Diagnosis Based On Paracrine Tubular Renin-Angiotensin System

    view source
  • US Patent:
    7749725, Jul 6, 2010
  • Filed:
    Oct 16, 2002
  • Appl. No.:
    10/271661
  • Inventors:
    Andreas Rohrwasser - Salt Lake City UT, US
    Terry Morgan - Salt Lake City UT, US
    Jean-Marc Lalouel - Salt Lake City UT, US
  • Assignee:
    University of Utah Research Foundation - Salt Lake City UT
  • International Classification:
    C07K 7/14
    C12Q 1/37
  • US Classification:
    435 23, 436 86, 514 2, 530316, 530860
  • Abstract:
    The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in an individual by measuring urinary angiotensinogen or angiotensin-I.
  • Molecular Variants, Haplotypes And Linkage Disequilibrium Within The Human Angiotensinogen Gene

    view source
  • US Patent:
    20030219776, Nov 27, 2003
  • Filed:
    Dec 18, 2002
  • Appl. No.:
    10/321844
  • Inventors:
    Jean-Marc Lalouel - Salt Lake City UT, US
    Andreas Rohrwasser - Salt Lake City UT, US
    Tomoaki Ishigami - Yokohama, JP
    Mitsuru Emi - Tokyo, JP
    Toshiaki Nakajima - Kawasaki, JP
    Ituro Inoue - Tokyo, JP
  • International Classification:
    C12Q001/68
  • US Classification:
    435/006000
  • Abstract:
    The present invention relates to methods for assessing risk of hypertension in als by identifying the molecular variants or haplotypes of the angiotensinogen (AGT) gene.
  • Method To Determine Predisposition To Hypertension

    view source
  • US Patent:
    61772526, Jan 23, 2001
  • Filed:
    Aug 27, 1999
  • Appl. No.:
    9/384212
  • Inventors:
    Andreas Rohrwasser - Salt Lake City UT
    Jean-Marc Lalouel - Salt Lake City UT
  • Assignee:
    University of Utah Research Foundation - Salt Lake City UT
  • International Classification:
    C12Q 168
    C07H 2104
  • US Classification:
    435 6
  • Abstract:
    The T/C(67) AGT gene variant and the association of the molecular variant C(67) with predisposition of an individual to hypertension are disclosed. The determination of this association enables the screening of persons to identify the severity of hypertension or the severity of the risk of a predisposition to high blood pressure.

Get Report for Andreas Rohrwasser from Salt Lake City, UT, age ~56
Control profile